Experiments for taxon Physalis peruviana (SOLANACEAE)

Experiments (159 results)

159 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
1237936	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Physalis peruviana (SOLANACEAE)
1056403	BIOSYNTHESISQUANTITATIVE DATAYIELD IS LESS THAN 50 MGMTLC DATA REPORTEDISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	TROPANE,3-ALPHA-TIGLOYL-OXY:
159383	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 9
899273	PLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Physalis peruviana (SOLANACEAE)	CYCLOARTENOL,24-METHYLENE:CYCLOARTENOL
1264146	IDENTIFICATION IN BY PAPER CHROMATOGRAPHY		Physalis peruviana (SOLANACEAE)	CHLOROGENIC ACID
618877	PLANT TISSUE CULTURE MARKER CODE		Physalis peruviana (SOLANACEAE)
170842	PHARMACOLOGY OF EXTRACT - IN VITRO	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)
229205	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	WITHAPHYSANOLIDE
229915	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	COAGULIN
1199936	MEDICINAL FOLKLORE REPORTED FOR	FOOD USE	Physalis peruviana (SOLANACEAE)
352074	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTHELMINTIC ACTIVITY	Physalis peruviana (SOLANACEAE)
149815	PHARMACOLOGY OF COMPOUND - IN VITRO	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)	ERGOSTA-5-TRANS-24-DIEN-26-OIC ACID,22-EPSILON-ACETOXY-1-ALPHA-3-BETA-DIHYDROXY: [GLUCUPYRANOSYL(1-4)-GLUCOPYRANOSYL-6''-ACETYL(1-2)-GLUCOPYRANOSYL ESTER]
159378	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 7
228658	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIFUNGAL ACTIVITY	Physalis peruviana (SOLANACEAE)	WITHA-3-5-24-TRIENOLIDE,22(R): 17-BETA-HYDROXY-14-20-EPOXY-1-OXO:
228653	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITHA-3-5-24-TRIENOLIDE,22(R): 17-BETA-HYDROXY-14-20-EPOXY-1-OXO:
1032855	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PERULACTONE B
1313523	MEDICINAL FOLKLORE REPORTED FOR		Physalis peruviana (SOLANACEAE)
419124	PHARMACOLOGY OF EXTRACT - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	INSECT REPELLENT ACTIVITY	Physalis peruviana (SOLANACEAE)
228659	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIFUNGAL ACTIVITY	Physalis peruviana (SOLANACEAE)	WITHA-3-5-24-TRIENOLIDE,22(R): 17-BETA-HYDROXY-14-20-EPOXY-1-OXO:
1255671	IDENTIFICATION IN BY GLC AFTER SAPONIFICATIONQUANTITATIVE DATA		Physalis peruviana (SOLANACEAE)	PALMITIC ACID
1237947	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIFERTILITY	SEMEN COAGULATION	Physalis peruviana (SOLANACEAE)
159374	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 5
205774	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	WITHANOLIDE E,4-BETA-HYDROXY:
159367	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 3
1056626	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITHAPERUVIN E
633439	MEDICINAL FOLKLORE REPORTED FOR	EYE PROBLEMS(UNSPECIFIED)	Physalis peruviana (SOLANACEAE)
159372	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 5
1237952	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	ANTICONVULSANT ACTIVITY	Physalis peruviana (SOLANACEAE)
406767	WRITE LETTER FOR 2 COMPOUNDSPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	WITHANOLIDE E
278471	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Physalis peruviana (SOLANACEAE)	PROPANE-1(S)-2(S)-DIOL,1-PHENYL: 2-O-BETA-D-GLUCOPYRANOSIDE
241377	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITHA-5-24-DIENOLIDE-3-BETA-(O-BETA-D-GLUCOPYRANOSIDE),14-ALPHA-20-27-TRIHYDROXY-1-OXO: (20R-22R):
1005596	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURETLC DATA REPORTED		Physalis peruviana (SOLANACEAE)	PHYSOPERUVINE,(+):
170843	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PERULACTONE-3-O-BETA-D-GLUCOSE
405295	WRITE LETTER FOR 2 COMPOUNDSPMR SPECTRUM REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	WITHANOLIDE E
899274	PLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Physalis peruviana (SOLANACEAE)	SITOSTEROL,BETA:
405296	PMR SPECTRUM REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	WITHANOLIDE E,2-3-DIHYDRO:
1237935	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Physalis peruviana (SOLANACEAE)
1237941	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Physalis peruviana (SOLANACEAE)
813572	PRESENT IN (REVIEW)QUANTITATIVE DATA		Physalis peruviana (SOLANACEAE)	WITHANOLIDE E,2-3-DIHYDRO:
159385	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 10
457915	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Physalis peruviana (SOLANACEAE)	WITHANOLIDE EWITHANOLIDE E,4-BETA-HYDROXY:
159379	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 7
193756	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	CINNAMIC ACID,TRANS: 1-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-GLUCOPYRANOSE
228657	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIFUNGAL ACTIVITY	Physalis peruviana (SOLANACEAE)	WITHA-3-5-24-TRIENOLIDE,22(R): 17-BETA-HYDROXY-14-20-EPOXY-1-OXO:
1237950	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	HYPOTHERMIC ACTIVITY	Physalis peruviana (SOLANACEAE)
352073	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTHELMINTIC ACTIVITY	Physalis peruviana (SOLANACEAE)
1237939	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY(PLANT PATHOGEN)	Physalis peruviana (SOLANACEAE)
828075	MEDICINAL FOLKLORE REPORTED FOR	FOOD USE	Physalis peruviana (SOLANACEAE)
229914	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	WITHAPERUVIN F
86414	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITHAPERUVIN F
618876	PLANT TISSUE CULTURE MARKER CODE		Physalis peruviana (SOLANACEAE)
241376	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITHA-5-24-DIENOLIDE-3-BETA-(O-BETA-D-GLUCOPYRANOSIDE),20-27-DIHYDROXY-1-OXO: (20R-22R):
1038039	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Physalis peruviana (SOLANACEAE)	PHYSALOLACTONE B-3-O-BETA-D-GLUCOPYRANOSIDE
1237949	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Physalis peruviana (SOLANACEAE)
159371	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 4
1255670	IDENTIFICATION IN BY GLC AFTER SAPONIFICATIONQUANTITATIVE DATA		Physalis peruviana (SOLANACEAE)	LINOLEIC ACID
908493	PLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Physalis peruviana (SOLANACEAE)	FUCOSTEROL,ISO:
278472	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Physalis peruviana (SOLANACEAE)	MENTH-4(8)-ENE-1-2-DIOL,PARA: 1-O-ALPHA-L-ARABINOPYRNAOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE
431229	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	QUERCETIN-3-O-ROBINOBIOSIDENICOTIFLORINRUTINKAEMPFEROL-3-O-ROBINOBIOSIDE-7-GLUCOSIDEKAEMPFEROL-3-RUTINOSIDE-7-GLUCOSIDEQUERCETIN-3-ROBINOBIOSIDE-7-GLUCOSIDEQUERCETIN-3-RUTINOSIDE-7-GLUCOSIDEKAEMPFEROL-3-ROBINOBIOSIDE
1037726	X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDCORRECTION OF STRUCTURECD SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	PHYSOPERUVINE
730466	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTITHROMBOTIC EFFECT	Physalis peruviana (SOLANACEAE)
149814	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	ERGOSTA-5-TRANS-24-DIEN-26-OIC ACID,22-EPSILON-ACETOXY-1-ALPHA-3-BETA-DIHYDROXY: [GLUCUPYRANOSYL(1-4)-GLUCOPYRANOSYL-6''-ACETYL(1-2)-GLUCOPYRANOSYL ESTER]
228656	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIFUNGAL ACTIVITY	Physalis peruviana (SOLANACEAE)	WITHA-3-5-24-TRIENOLIDE,22(R): 17-BETA-HYDROXY-14-20-EPOXY-1-OXO:
43217	IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)
1237946	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIFERTILITY	SPERMICIDAL EFFECT	Physalis peruviana (SOLANACEAE)
1056404	BIOSYNTHESISQUANTITATIVE DATAYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	TIGLIOIDINE
229204	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PHYSABUBENOLIDE,15-DEACETYL:
101746	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Physalis peruviana (SOLANACEAE)	WITHAPERUVIN H
1251601	PRESENT IN (REVIEW)		Physalis peruviana (SOLANACEAE)	WITHANOLIDE E,2-3-DIHYDRO:WITHANOLIDE EWITHANOLIDE E,4-BETA-HYDROXY:PHYSALIN A
818964	PLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Physalis peruviana (SOLANACEAE)	BRASSICASTEROL,DIHYDRO:CAMPESTEROL
1022215	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PHYSALOLACTONE B
159368	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 3
1005597	PMR SPECTRUM REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURETLC DATA REPORTED		Physalis peruviana (SOLANACEAE)	PHYSOPERUVINIUM,N-N-DIMETHYL: (+):
159375	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 6
241374	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITHA-5-24-DIENOLIDE-3-BETA-(O-BETA-D-GLUCOPYRANOSIDE),1-ALPHA-ACETOXY-14-ALPHA-20-DIHYDROXY: (20R-22R):
159382	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 9
1005546	PHARMACOLOGY OF EXTRACT - IN VITRO	FEEDING DETERRENT(INSECT)	Physalis peruviana (SOLANACEAE)
170840	PHARMACOLOGY OF EXTRACT - IN VITRO	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)
241379	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	PHYSALOLACTONE B GLUCOSIDE
1005598	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURETLC DATA REPORTED		Physalis peruviana (SOLANACEAE)	PHYSOPERUVINE,(DL):
140989	ISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	PHYGRINE
159365	VOUCHER SPECIMEN REPORTED FOR		Physalis peruviana (SOLANACEAE)
633436	VOUCHER SPECIMEN REPORTED FOR		Physalis peruviana (SOLANACEAE)
1237938	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Physalis peruviana (SOLANACEAE)
1048045	PLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Physalis peruviana (SOLANACEAE)	CLIONASTEROLSITOSTEROL,BETA:
159386	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 10
730464	VOUCHER SPECIMEN REPORTED FOR		Physalis peruviana (SOLANACEAE)
241375	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITHA-5-24-DIENOLIDE-3-BETA-(O-BETA-D-GLUCOPYRANOSIDE),1-ALPHA-ACETOXY-27-HYDROXY: (20S-22R):
1237942	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Physalis peruviana (SOLANACEAE)
159373	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 5
1237934	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	TOXICITY ASSESSMENT(QUANTITATIVE)	Physalis peruviana (SOLANACEAE)
159381	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 9
1237954	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Physalis peruviana (SOLANACEAE)
149817	PHARMACOLOGY OF COMPOUND - IN VITRO	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)	ERGOSTA-5-TRANS-24-DIEN-26-OIC ACID,22-EPSILON-ACETOXY-1-ALPHA-3-BETA-DIHYDROXY: [GLUCOPYRANOSYL-6'''-ACETOXY(1-4)-GLUCOPYRANOSYL-6''-ACETOXY-GLUCOPYRANOSYL ESTER]
229203	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITH-24-ENOLIDE,5-ALPHA-6-BETA-14-ALPHA-20(R)-27-PENTAHYDROXY-1-OXO: 22(R):
980854	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	WITHANOLIDE S
228655	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIFUNGAL ACTIVITY	Physalis peruviana (SOLANACEAE)	WITHA-3-5-24-TRIENOLIDE,22(R): 17-BETA-HYDROXY-14-20-EPOXY-1-OXO:
1237940	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Physalis peruviana (SOLANACEAE)
633437	MEDICINAL FOLKLORE REPORTED FOR	MISCELLANEOUS EFFECTS	Physalis peruviana (SOLANACEAE)
1056405	BIOSYNTHESISQUANTITATIVE DATAYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	TROPANE,3-ALPHA-TIGLOYL-OXY:
837778	ISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	ERGOSTA-14-24-DIEN-22(R)-26-OLIDE,4-BETA-5-BETA-17(S)-BETA-2O(S)-ALPHA-TETRAHYDROXY-3(R)-ALPHA-6(S)-ALPHA-OXIDO-1-OXO:ERGOST-24-EN-22(R)-26-OLIDE,2-BETA-3-BETA: 5-BETA-6-BETA-DIEPOXY-14-ALPHA-17(S)-BETA-20(S)-ALPHA-F-TRIHYDROXY-1-OXO:
1237951	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	ANALGESIC ACTIVITY	Physalis peruviana (SOLANACEAE)
1237945	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Physalis peruviana (SOLANACEAE)
813571	PRESENT IN (REVIEW)QUANTITATIVE DATA		Physalis peruviana (SOLANACEAE)	WITHANOLIDE E,4-BETA-HYDROXY:
159384	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 10
826127	ISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	RUTINWITHANOLIDE E,4-BETA-HYDROXY:SITOSTEROL,BETA:DAUCOSTEROLPHYSALOLACTONE
406766	WRITE LETTER FOR 2 COMPOUNDSPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE		Physalis peruviana (SOLANACEAE)	WITHANOLIDE E,4-BETA-HYDROXY:
170844	PHARMACOLOGY OF COMPOUND - IN VITRO	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)	PERULACTONE-3-O-BETA-D-GLUCOSE
878019	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PHYSALOLACTONE,23-HYDROXY:
159369	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 4
405297	PMR SPECTRUM REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	PHYSALIN A
426268	PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Physalis peruviana (SOLANACEAE)	FUCOSTEROL,ISO:CHOLESTEROL,24-METHYLENE:SITOSTEROL,BETA:
1008558	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PHYSALOLACTONE,4-DEOXY:
159370	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 4
1002724	ISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	PHYSOPERUVINEPHYSOPERUVINE,DIHYDRO:PHYSOPERUVINIUM
813569	PRESENT IN (REVIEW)QUANTITATIVE DATAREVIEW OF		Physalis peruviana (SOLANACEAE)	PHYSALIN A
159376	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 6
149816	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	ERGOSTA-5-TRANS-24-DIEN-26-OIC ACID,22-EPSILON-ACETOXY-1-ALPHA-3-BETA-DIHYDROXY: [GLUCOPYRANOSYL-6'''-ACETOXY(1-4)-GLUCOPYRANOSYL-6''-ACETOXY-GLUCOPYRANOSYL ESTER]
1057818	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PHYSALOLACTONE C
170841	PHARMACOLOGY OF EXTRACT - IN VITRO	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)
159377	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 6
1217886	MEDICINAL FOLKLORE REPORTED FOR	HEMOSTATIC ACTIVITY	Physalis peruviana (SOLANACEAE)
205781	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Physalis peruviana (SOLANACEAE)	WITHAPERUVIN E
159380	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Physalis peruviana (SOLANACEAE)	PHYSALIS ERGOSTENE GLYCOSIDE ESTER 7
229206	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	VISCOSALACTONE B
892919	PMR SPECTRUM REPORTEDPLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDBIOSYNTHESISQUANTITATIVE DATAISOLATION FROM DURING BIOSYNTHESIS STUDY		Physalis peruviana (SOLANACEAE)	CYCLOARTENOL
1034272	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Physalis peruviana (SOLANACEAE)	WITHANOLIDE E,2-3-DIHYDRO:WITHANOLIDE SWITHANOLIDE EWITHANOLIDE E,4-BETA-HYDROXY:
1002457	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Physalis peruviana (SOLANACEAE)	PHYSALOLACTONE B
1089758	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITHAPERUVIN CWITHAPERUVIN B
228654	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIFUNGAL ACTIVITY	Physalis peruviana (SOLANACEAE)	WITHA-3-5-24-TRIENOLIDE,22(R): 17-BETA-HYDROXY-14-20-EPOXY-1-OXO:
1092622	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY(PLANT PATHOGENS)	Physalis peruviana (SOLANACEAE)
1237948	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	HYPOGLYCEMIC ACTIVITY	Physalis peruviana (SOLANACEAE)
1002967	CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Physalis peruviana (SOLANACEAE)	DESMOSTEROL,24-METHYL:
1255672	IDENTIFICATION IN BY GLC AFTER SAPONIFICATIONQUANTITATIVE DATA		Physalis peruviana (SOLANACEAE)	STEARIC ACID
86415	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITHAPERUVIN G
730465	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTITHROMBOTIC EFFECT	Physalis peruviana (SOLANACEAE)
1237943	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Physalis peruviana (SOLANACEAE)
482888	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY GC/MS		Physalis peruviana (SOLANACEAE)	CUSCOHYGRINETROPANE,3-ALPHA-TIGLOYL:HYGRINETROPINEHYGRINE B,N-METHYL-PYRROLIDINYL:PHYSOPERUVINEHYGRINE A,N-METHYL-PYRROLIDINYL:TROPANE,3-BETA-ACETOXY:
205773	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Physalis peruviana (SOLANACEAE)	WITHANOLIDE E,28-HYDROXY:
1002968	ISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	CHOLESTEROL,24-METHYLENE:
1237944	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Physalis peruviana (SOLANACEAE)
618875	PLANT TISSUE CULTURE MARKER CODE		Physalis peruviana (SOLANACEAE)
352075	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTHELMINTIC ACTIVITY	Physalis peruviana (SOLANACEAE)
1008557	UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITHAPERUVIN
1237953	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	DIURETIC ACTIVITY	Physalis peruviana (SOLANACEAE)
1255669	IDENTIFICATION IN BY GLC AFTER SAPONIFICATIONQUANTITATIVE DATA		Physalis peruviana (SOLANACEAE)	OLEIC ACID
813570	PRESENT IN (REVIEW)QUANTITATIVE DATA		Physalis peruviana (SOLANACEAE)	WITHANOLIDE E
241378	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	PHYSALOLACTONE B
1056402	BIOSYNTHESISQUANTITATIVE DATAYIELD IS LESS THAN 50 MGMTLC DATA REPORTEDISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	TIGLIOIDINE
170845	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PERULACTONE,ISO: 3-O-BETA-D-GLUCOSIDE
419125	PHARMACOLOGY OF EXTRACT - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	INSECT REPELLENT ACTIVITY	Physalis peruviana (SOLANACEAE)
229913	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITHA-5-24-DIENOLIDE,17-BETA-HYDROXY-14-20-EPOXY-1-OXO-[OXO-[22(R)]-3-BETA-(O-BETA-D-GLUCOPYRANOSYL):
159366	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LARVAL GROWTH INHIBITION	Physalis peruviana (SOLANACEAE)
405294	WRITE LETTER FOR 2 COMPOUNDSPMR SPECTRUM REPORTEDYIELD IS MORE THAN 100 MGMORD SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE		Physalis peruviana (SOLANACEAE)	WITHANOLIDE E,4-BETA-HYDROXY:
1056627	ISOLATION AND IDENTIFICATION OF		Physalis peruviana (SOLANACEAE)	PHYSALOLACTONE
1237937	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Physalis peruviana (SOLANACEAE)
1040788	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	WITHAPERUVIN D
633438	MEDICINAL FOLKLORE REPORTED FOR	GASTROINTESTINAL DISORDERS(UNSPECIFIED)	Physalis peruviana (SOLANACEAE)
1009332	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis peruviana (SOLANACEAE)	PERULACTONE

Experiments for taxon Physalis peruviana (SOLANACEAE)

Experiments (159 results)

Filters

Worktypes (39)

Pharmacology (29)

Compounds (90)

Organisms (66)